The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

GRAYLING, MI – A Northern Michigan defense training complex based out of Camp Grayling has been chosen by the federal government to test and train drones. The announcement made this week by the ...

Artificial-intelligence giant OpenAI is about to stick ads in its popular ChatGPT application for some users — but the company insists it will have measures in place to protect users’ privacy and ...

The latest WhatsApp TestFlight build introduces sticker suggestions, eliminating the extra steps of having to open and sift through the sticker panel. Here’s how it works. As spotted by WABetaInfo, ...

Yann LeCun, Meta’s outgoing chief AI scientist, says his employer tested its latest Llama model in a way that may have made the model look better than it really was. In a recent Financial Times ...

Electrochemical impedance spectroscopy (EIS) provides valuable insights into the physical processes within batteries – but how can these measurements directly inform physics-based models? In this ...

It’s finally happening. After years of promises, missed timelines dating back to the “Autonomy Day” in 2019, and endless iterations of “Full Self-Driving” (FSD), a Tesla vehicle has been spotted ...

How much have we covered so far, and how much more is pending? I would not be surprised to know that you keep hearing this question in your job as a software tester. When it comes to testing, everyone ...

Swiss start-up Jekta plans next month to begin flight testing a scale model of the amphibious hydrogen-electric passenger aircraft it aims to bring to market next decade. The company released images ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...